Nimesh Shah

Nimesh joined Domain Associates in 2006 and became a partner in 2013.  He has been instrumental in investing in and helping start new medical device companies.

Nimesh is a co-founder and current board member of Zyga Technology and a board member of Benvenue Medical, Cotera, Fractyl Laboratories, Miramar Labs, and Sequent Medical, and is a board observer at ReVision Optics.  He also served on the board of The Foundry company Twelve until its acquistion by Medtronic.  He had previously been involved as an observer with REVA Medical, Tandem Diabetes Care and Zogenix, all of which completed successful public offerings.

Prior to Domain, Nimesh was a part of the investment team at venture firm Cutlass Capital where he was involved with that firm’s investments in Apneon, GI Dynamics, Titan Health, and TranS1. Previous to that, Nimesh worked at Alex. Brown & Sons (now Deutsche Bank) serving as a member of the medical device equity research team.

Nimesh received his B.S. in biomedical engineering from Johns Hopkins University. While in school, he worked supporting the investment team at Alex. Brown Capital Advisory & Trust. He also spent time at Johns Hopkins Hospital involved in a project that aimed to map the functional areas of the brain.

He currently serves as a board member for the San Diego Venture Group.